National AIDS Research Institute, Pune Report issue

Academic/Hospital Phase 1 Phase 3

Organization Overview

First Clinical Trial
2004
NCT00081640
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

NARI Pune CRS | National AIDS Research Institute, Pune, India

Active Ingredients

Drugs in Phase 3 Trials (2)

gentian violet (genapax) (1 trial)

nystatin (mycostatin) (1 trial)

Drugs in Phase 1 Trials (1)

tenofovir (viread) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Candidiasis (Phase 3)

HIV Infections (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3